Biocon Ltd. — Regulatory Filings 2020

Sep 21, 2020

==> picture [119 x 47] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

Date of submission: September 21, 2020

To	To
The Secretary	The Secretary
BSE Limited	National Stock Exchange of India Limited
Department of Corporate Services	Corporate Communication Department
Phiroze Jeejeebhoy Towers,	Exchange Plaza, Bandra Kurla Complex
Dalal Street,Mumbai – 400 001	Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol- BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor / Research Analysts:

Date	Name	Type ofmeeting	Location
	Aberdeen Asset Management Ltd
	Aberdeen Standard Investments
	Amundi Asset Management
	APG Asset Management - HongKong
	AR Capital Pte Ltd
	Axis Mutual Fund	Virtual
September 21, 2020	Canada Pension Plan Investment Board	Meetings - 1x1	Bangalore
	Federated Investors - US	& Group
	Fullerton Fund Management
	HSBC Global Asset Management(UK)Limited
	Marshall Wace Asset Management - United Kingdom
	SamsungAsset Management(HongKong)Limited
	UBS Asset Management - Singapore

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [78 x 30] intentionally omitted <==

_______________ Mayank Verma Company Secretary and Compliance Officer